IHI catalysts
Catalysts and events linked to IHI, newest first.
IHI stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Abbott Laboratories Rises 2.2% Ahead of Q3 Results Projecting 13.5% Top-Line Growth 2026-10-13 · Up | surgical procedure recovery pass-through to medical device equipment index | Abbott is a core constituent in medical devices benchmark. | Not recorded |
| Cooper Companies Cuts Organic FY Guidance on U.S. Channel Destocking 2026-09-13 · Down | medical device supply chain inventory headwinds | Cooper Companies is a specialized constituent in medical devices and optical care portfolios. | Not recorded |
Do these developments change your position?
Review IHI alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-10-13Abbott Laboratories Rises 2.2% Ahead of Q3 Results Projecting 13.5% Top-Line GrowthABT IHI XLV+2.53%
- 2026-09-13Cooper Companies Cuts Organic FY Guidance on U.S. Channel DestockingIHI
- 2026-09-13Cooper Companies Cuts Organic FY Guidance on U.S. Channel DestockingIHI
- 2026-09-13Cooper Companies Cuts Organic FY Guidance on U.S. Channel DestockingCOO IHI
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.